Industry / Hungary
Liberalisation Impacting Pharmacies
December 2007 | Industry NewsBMI expects Hungary's OTC market to reach a value of US$0.8bn driven by growing health awareness in the county, increased consumer spending and, more recently, the liberalisation of the pharmacy sector. However, pharmacies are complaining about the new laws which they claim are eating into revenues.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
